SOLIGENIX, INC. (SNGX) Files Proxy Statement Ahead of Shareholder Meeting
Filing Details SOLIGENIX, INC. (NASDAQ:SNGX) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on August 03, 2026. The Healthcare company's…
Read more
